Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomically constrained deep learning for clinical-grade volumetric pancreatic cancer segmentation: development, validation, and architectural benchmarking.

NPJ precision oncology·2026
Same author

Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories.

ArXiv·2026
Same author

Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability.

Gut·2026
Same author

Blood Urea Nitrogen-to-Creatinine Ratio to Differentiate Upper From Lower Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

Journal of gastroenterology and hepatology·2026
Same author

Interpretive consistency of a qualitative <sup>68</sup>Ga-PSMA PET framework for treatment response assessment in hepatocellular carcinoma: a head-to-head comparison with cross-sectional imaging.

European journal of nuclear medicine and molecular imaging·2025

Related Experiment Video

Updated: Sep 18, 2025

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

11.0K

Artificial Intelligence-Augmented Imaging for Early Pancreatic Cancer Detection.

Ajith Antony1, Sovanlal Mukherjee1, Khurram Bhinder1

  • 1Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Visceral Medicine
|June 26, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) can detect pancreatic ductal adenocarcinoma (PDA) earlier than standard methods by analyzing CT scans for subtle changes. This AI approach promises improved early detection and diagnosis of this lethal cancer.

Keywords:
Artificial intelligenceComputed tomographyDeep learningDetectionPancreatic ductal adenocarcinoma

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

275
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

675

Related Experiment Videos

Last Updated: Sep 18, 2025

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

11.0K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

275
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

675

Area of Science:

  • Oncology
  • Radiology
  • Artificial Intelligence

Background:

  • Pancreatic ductal adenocarcinoma (PDA) is a lethal cancer often diagnosed late due to limited early detection.
  • Current contrast-enhanced computed tomography (CT) has diagnostic limitations including interobserver variability and subtle early-stage findings.

Purpose of the Study:

  • To explore the potential of artificial intelligence (AI) in improving the early detection and diagnosis of pancreatic ductal adenocarcinoma (PDA).
  • To leverage AI-driven radiomics and deep learning for identifying subtle imaging biomarkers of PDA on CT scans.

Main Methods:

  • Utilizing radiomics and deep learning models to analyze CT scans for subtle pancreatic textural and structural changes.
  • Employing automated volumetric pancreas segmentation to enhance reproducibility and biomarker discovery.

Main Results:

  • AI models demonstrated the ability to detect pre-diagnostic PDA on CT scans months to years before clinical presentation.
  • AI can identify subtle imaging signatures imperceptible to the human eye, aiding in early carcinogenesis detection.

Conclusions:

  • AI offers a transformative approach to augment CT-based PDA detection and reduce diagnostic uncertainty.
  • Further research including external validation, clinical workflow integration, and prospective trials is crucial for establishing AI in PDA diagnosis and staging.